Interviews

Ron Lanton III, Esq, president, True North Political Solutions, LLC, explains how mobile health can affect specialty pharmacies.

Joel Wright, chief executive officer, Alliance Rx Walgreens Prime discusses how technology has influenced the way specialty pharmacists manage patient care.

Jonathan Ogurchak, PharmD, CSP, vice president of Business Operations at PANTHERx Specialty Pharmacy, discusses the best strategies to ensure patient satisfaction.

Bruce A. Feinberg, DO, vice president and chief medical officer of Cardinal Health Specialty Solutions, discusses the key elements of an effective cancer clinical care pathways program.

Advice from a pharmacist for patients who are dealing with nail fungus.

Rina Shah, PharmD, Vice President, Pharmacy Operations and Specialty Pharmacy, Walgreens, talks about the importance of care coordination.

Marcus H. Snow, MD, of the University of Nebraska Medical Center, discusses the importance of the treat-to target-strategy versus the non-targeted therapeutic approach in patients with rheumatoid arthritis.

Brandon Shank, PharmD, MPH, BCOP, discusses how pharmacists work with patients undergoing chemotherapy through transitions of care.

Sheena Babin, PharmD, business development and clinical pharmacy manager at Ochsner Health System, discusses changes specialty pharmacists will need to make to ensure adherence of self-administered specialty drugs.

Bruce A. Feinberg, DO, Vice President and Chief Medical Officer of Cardinal Health Specialty Solutions, discusses the expanding role of educational patient support programs in oncology.

Rinku Patel, PharmD, RPh, CEO and founder of KloudScript, discusses the impact of direct and indirect remuneration (DIR) fees.

Marcus H. Snow, MD, of the University of Nebraska Medical Center, discusses how education and counseling can improve the uptake of biosimilars among rheumatologists and patients.

Brandon Shank, PharmD, MPH, BCOP, discusses the role of the oncology pharmacist in providing consultation and maintaining communication with cancer patients during treatment.

Bruce A. Feinberg, DO, Vice President and Chief Medical Officer of Cardinal Health Specialty Solutions, discusses the importance of specialty pharmacists in a patient-centric environment.

Clinical pharmacists have the oppurtunity to enhance the care of patients through medication expertise.

With a shift from intravenous to self-administered medication, specialty pharmacists are key in patient education.

Bruce A. Feinberg, DO, Vice President and Chief Medical Officer of Cardinal Health Specialty Solutions speaks about the possible change of the pathway program due to alternative payment models, such as the Oncology Care Model.

Mike Agostino, RPh, president at Amber Pharmacy, president-elect at NASP, talks about the exciting things for this year's NASP Annual Meeting, including keynote speaker, Alex Azar, former president at Eli Lilly.

What is the importance and prevalence of treat-to-target?

Bruce A. Feinberg, DO, Vice President and Chief Medical Officer of Cardinal Health Specialty Solutions, talks about the role pharmacists can play in potential education for patients outside of the oncology clinic.

Pharmacists play an important role in counseling patients on biologics.

Jon Gavras, MD, chief medical officer at Prime Therapeutics, explores how combining medical and pharmacy benefits could result in a better understanding of a certain drug's value.

Pharmacists' increasing role in providing patient education and contact.

Rina Shah, PharmD, Vice President, Pharmacy Operations and Specialty Pharmacy, Walgreens, discusses how operating a specialty pharmacy associated with a retail pharmacy can be beneficial.

Moses Zonana, CEO of Compliance Meds Technologies, discusses ways technology can be utilized to monitor adherence.

Ron Lanton III, Esq, president of True North Political Solutions, LLC, discusses how recently proposed transparency legislation may affect specialty pharmacies.

Jonathan Ogurchak, PharmD, CSP, vice president of Business Operations at PANTHERx Specialty Pharmacy, discusses how to increase the utilization of biosimilars across the industry.